MACK

Merrimack Pharmaceuticals, Inc.
MACK

Overview Fund Activity
Delisted

MACK was delisted on the 17th of May, 2024.

Back to rankings

2 hedge funds and large institutions have $0 invested in Merrimack Pharmaceuticals, Inc. in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-10
Holders Change %
-83.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
$0
2
Goldman Sachs
Goldman Sachs
New York
$0
3
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
$0
4
JC
JBF Capital
Colorado
$0
5
Marshall Wace
Marshall Wace
United Kingdom
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Dimensional Fund Advisors
1
Dimensional Fund Advisors
Texas
– -$4.83M -318,995 Closed
JC
2
JBF Capital
Colorado
– -$1.19K -39,637 Closed
Marshall Wace
3
Marshall Wace
United Kingdom
– -$1.15K -38,221 Closed
Goldman Sachs
4
Goldman Sachs
New York
– -$451K -29,807 Closed
RhumbLine Advisers
5
RhumbLine Advisers
Massachusetts
– -$37.5K -2,480 Closed